Tsutomu Fukuda Selected Research

lamellarin N

12/2017

Design, synthesis, and evaluation of A-ring-modified lamellarin N analogues as noncovalent inhibitors of the EGFR T790M/L858R mutant.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tsutomu Fukuda Research Topics

Disease

4	Neoplasms (Cancer) 09/2022 - 09/2013
2	Lung Neoplasms (Lung Cancer) 09/2022 - 10/2018
2	Infections 01/2022 - 12/2011
1	Metaplasia 09/2022
1	Pneumothorax 09/2022
1	Respiratory Aspiration 10/2021
1	Carcinoma (Carcinomatosis) 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2013

Drug/Important Bio-Agent (IBA)

1	phytobacteriomycin (PBM)IBA 09/2022
1	AlkaloidsIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	calcium polycarbophil (polycarbophil)IBA 10/2021
1	CalciumIBA 10/2021
1	lamellarin 14IBA 05/2021
1	EstersIBA 01/2019
1	Valine (L-Valine)FDA Link 01/2019
1	CamptothecinIBA 01/2019
1	lamellarin DIBA 01/2019
1	AsbestosIBA 10/2018
1	lamellarin NIBA 12/2017
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 09/2013
1	Phosphotransferases (Kinase)IBA 09/2013
1	Protein Kinases (Protein Kinase)IBA 09/2013
1	Cyclin AIBA 09/2013
1	Cyclin BIBA 09/2013
1	Sulfates (Sulfates, Inorganic)IBA 12/2011